Wolff Wiese Magana’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.8K Buy
3,854
+878
+30% +$23K 0.04% 176
2026
Q1
$83.6K Buy
2,976
+14
+0.5% +$373 0.05% 170
2025
Q4
$73.8K Sell
2,962
-166
-5% -$4.19K 0.04% 172
2025
Q3
$79.7K Sell
3,128
-329
-10% -$8.12K 0.05% 172
2025
Q2
$83.8K Buy
3,457
+110
+3% +$2.56K 0.05% 162
2025
Q1
$84.8K Buy
3,347
+158
+5% +$4.13K 0.06% 149
2024
Q4
$84.6K Sell
3,189
-153
-5% -$4.15K 0.06% 151
2024
Q3
$96.7K Buy
3,342
+1,741
+109% +$50.8K 0.07% 143
2024
Q2
$44.8K Sell
1,601
-379
-19% -$10.4K 0.04% 173
2024
Q1
$55K Sell
1,980
-38,607
-95% -$1.07M 0.05% 136
2023
Q4
$1.17M Sell
40,587
-3,994
-9% -$121K 1.11% 32
2023
Q3
$1.48M Sell
44,581
-2,523
-5% -$89.2K 1.2% 27
2023
Q2
$1.73M Buy
47,104
+6,851
+17% +$267K 1.33% 23
2023
Q1
$1.64M Buy
40,253
+1,821
+5% +$78.7K 1.33% 23
2022
Q4
$1.97M Buy
38,432
+130
+0.3% +$6.23K 1.69% 15
2022
Q3
$1.68M Buy
38,302
+5,837
+18% +$284K 1.35% 18
2022
Q2
$1.7M Buy
32,465
+836
+3% +$42.6K 1.24% 22
2022
Q1
$1.64M Buy
31,629
+978
+3% +$50.7K 1.1% 26
2021
Q4
$1.81M Sell
30,651
-3,628
-11% -$180K 1.17% 19
2021
Q3
$1.47M Buy
34,279
+500
+1% +$22.1K 1.04% 25
2021
Q2
$1.32M Buy
33,779
+377
+1% +$14.7K 0.94% 29
2021
Q1
$1.21M Buy
33,402
+1,777
+6% +$63.1K 0.95% 32
2020
Q4
$1.16M Buy
+31,625
New +$1.16M 0.98% 30

Other funds holding PFE

Wolff Wiese Magana's PFE Position: Q2 2026 in Review

Wolff Wiese Magana increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $23K and bringing the position to 3,854 shares worth $92.8K. The position accounts for 0.04% of the portfolio, ranked #176.

Wolff Wiese Magana first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.97M in Q4 2022. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wolff Wiese Magana held 3,854 shares of Pfizer worth $92.8K as of Q2 2026.
  • Wolff Wiese Magana bought 878 Pfizer shares in Q2 2026, an estimated $23K.
  • Pfizer made up 0.04% of Wolff Wiese Magana's portfolio in Q2 2026, its #176 holding.
  • Wolff Wiese Magana first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Pfizer position peaked at $1.97M in Q4 2022.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.